The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In Vitro ADME-Tox Market Research Report 2025
Synopsis
In the early stages of drug discovery, it is important to understand the key physicochemical properties and structural motifs that drive the efficacy and safety profile of a compound candidate. In vitro ADME is used to identify the attributes of absorption, distribution, metabolism, and excretion. ADME assays are critical in gaining insight into metabolism and potential drug interactions.
The global In Vitro ADME-Tox market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In Vitro ADME-Tox, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro ADME-Tox.
Report Scope
The In Vitro ADME-Tox market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro ADME-Tox market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro ADME-Tox companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segment by Type
Small Molecules
Biologics
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro ADME-Tox companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In the early stages of drug discovery, it is important to understand the key physicochemical properties and structural motifs that drive the efficacy and safety profile of a compound candidate. In vitro ADME is used to identify the attributes of absorption, distribution, metabolism, and excretion. ADME assays are critical in gaining insight into metabolism and potential drug interactions.
The global In Vitro ADME-Tox market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In Vitro ADME-Tox, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro ADME-Tox.
Report Scope
The In Vitro ADME-Tox market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro ADME-Tox market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro ADME-Tox companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segment by Type
Small Molecules
Biologics
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro ADME-Tox companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro ADME-Tox Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global In Vitro ADME-Tox Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro ADME-Tox Market Perspective (2019-2030)
2.2 In Vitro ADME-Tox Growth Trends by Region
2.2.1 Global In Vitro ADME-Tox Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro ADME-Tox Historic Market Size by Region (2019-2024)
2.2.3 In Vitro ADME-Tox Forecasted Market Size by Region (2025-2030)
2.3 In Vitro ADME-Tox Market Dynamics
2.3.1 In Vitro ADME-Tox Industry Trends
2.3.2 In Vitro ADME-Tox Market Drivers
2.3.3 In Vitro ADME-Tox Market Challenges
2.3.4 In Vitro ADME-Tox Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro ADME-Tox Players by Revenue
3.1.1 Global Top In Vitro ADME-Tox Players by Revenue (2019-2024)
3.1.2 Global In Vitro ADME-Tox Revenue Market Share by Players (2019-2024)
3.2 Global In Vitro ADME-Tox Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro ADME-Tox Revenue
3.4 Global In Vitro ADME-Tox Market Concentration Ratio
3.4.1 Global In Vitro ADME-Tox Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro ADME-Tox Revenue in 2023
3.5 In Vitro ADME-Tox Key Players Head office and Area Served
3.6 Key Players In Vitro ADME-Tox Product Solution and Service
3.7 Date of Enter into In Vitro ADME-Tox Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro ADME-Tox Breakdown Data by Type
4.1 Global In Vitro ADME-Tox Historic Market Size by Type (2019-2024)
4.2 Global In Vitro ADME-Tox Forecasted Market Size by Type (2025-2030)
5 In Vitro ADME-Tox Breakdown Data by Application
5.1 Global In Vitro ADME-Tox Historic Market Size by Application (2019-2024)
5.2 Global In Vitro ADME-Tox Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vitro ADME-Tox Market Size (2019-2030)
6.2 North America In Vitro ADME-Tox Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vitro ADME-Tox Market Size by Country (2019-2024)
6.4 North America In Vitro ADME-Tox Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro ADME-Tox Market Size (2019-2030)
7.2 Europe In Vitro ADME-Tox Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vitro ADME-Tox Market Size by Country (2019-2024)
7.4 Europe In Vitro ADME-Tox Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro ADME-Tox Market Size (2019-2030)
8.2 Asia-Pacific In Vitro ADME-Tox Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vitro ADME-Tox Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vitro ADME-Tox Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro ADME-Tox Market Size (2019-2030)
9.2 Latin America In Vitro ADME-Tox Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vitro ADME-Tox Market Size by Country (2019-2024)
9.4 Latin America In Vitro ADME-Tox Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro ADME-Tox Market Size (2019-2030)
10.2 Middle East & Africa In Vitro ADME-Tox Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vitro ADME-Tox Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vitro ADME-Tox Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River In Vitro ADME-Tox Introduction
11.1.4 Charles River Revenue in In Vitro ADME-Tox Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In Vitro ADME-Tox Introduction
11.2.4 Labcorp Revenue in In Vitro ADME-Tox Business (2019-2024)
11.2.5 Labcorp Recent Development
11.3 Envigo
11.3.1 Envigo Company Detail
11.3.2 Envigo Business Overview
11.3.3 Envigo In Vitro ADME-Tox Introduction
11.3.4 Envigo Revenue in In Vitro ADME-Tox Business (2019-2024)
11.3.5 Envigo Recent Development
11.4 Curia
11.4.1 Curia Company Detail
11.4.2 Curia Business Overview
11.4.3 Curia In Vitro ADME-Tox Introduction
11.4.4 Curia Revenue in In Vitro ADME-Tox Business (2019-2024)
11.4.5 Curia Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec In Vitro ADME-Tox Introduction
11.5.4 Evotec Revenue in In Vitro ADME-Tox Business (2019-2024)
11.5.5 Evotec Recent Development
11.6 Bioduro-Sundia
11.6.1 Bioduro-Sundia Company Detail
11.6.2 Bioduro-Sundia Business Overview
11.6.3 Bioduro-Sundia In Vitro ADME-Tox Introduction
11.6.4 Bioduro-Sundia Revenue in In Vitro ADME-Tox Business (2019-2024)
11.6.5 Bioduro-Sundia Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza In Vitro ADME-Tox Introduction
11.7.4 Lonza Revenue in In Vitro ADME-Tox Business (2019-2024)
11.7.5 Lonza Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Detail
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec In Vitro ADME-Tox Introduction
11.8.4 WuXi AppTec Revenue in In Vitro ADME-Tox Business (2019-2024)
11.8.5 WuXi AppTec Recent Development
11.9 IQVIA
11.9.1 IQVIA Company Detail
11.9.2 IQVIA Business Overview
11.9.3 IQVIA In Vitro ADME-Tox Introduction
11.9.4 IQVIA Revenue in In Vitro ADME-Tox Business (2019-2024)
11.9.5 IQVIA Recent Development
11.10 Tecan Group
11.10.1 Tecan Group Company Detail
11.10.2 Tecan Group Business Overview
11.10.3 Tecan Group In Vitro ADME-Tox Introduction
11.10.4 Tecan Group Revenue in In Vitro ADME-Tox Business (2019-2024)
11.10.5 Tecan Group Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Detail
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron In Vitro ADME-Tox Introduction
11.11.4 Pharmaron Revenue in In Vitro ADME-Tox Business (2019-2024)
11.11.5 Pharmaron Recent Development
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Detail
11.12.2 Shanghai Medicilon Business Overview
11.12.3 Shanghai Medicilon In Vitro ADME-Tox Introduction
11.12.4 Shanghai Medicilon Revenue in In Vitro ADME-Tox Business (2019-2024)
11.12.5 Shanghai Medicilon Recent Development
11.13 ChemPartner
11.13.1 ChemPartner Company Detail
11.13.2 ChemPartner Business Overview
11.13.3 ChemPartner In Vitro ADME-Tox Introduction
11.13.4 ChemPartner Revenue in In Vitro ADME-Tox Business (2019-2024)
11.13.5 ChemPartner Recent Development
11.14 Joinn Laboratories
11.14.1 Joinn Laboratories Company Detail
11.14.2 Joinn Laboratories Business Overview
11.14.3 Joinn Laboratories In Vitro ADME-Tox Introduction
11.14.4 Joinn Laboratories Revenue in In Vitro ADME-Tox Business (2019-2024)
11.14.5 Joinn Laboratories Recent Development
11.15 RTI International
11.15.1 RTI International Company Detail
11.15.2 RTI International Business Overview
11.15.3 RTI International In Vitro ADME-Tox Introduction
11.15.4 RTI International Revenue in In Vitro ADME-Tox Business (2019-2024)
11.15.5 RTI International Recent Development
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Detail
11.16.2 Eurofins Scientific Business Overview
11.16.3 Eurofins Scientific In Vitro ADME-Tox Introduction
11.16.4 Eurofins Scientific Revenue in In Vitro ADME-Tox Business (2019-2024)
11.16.5 Eurofins Scientific Recent Development
11.17 Aragen Life Sciences
11.17.1 Aragen Life Sciences Company Detail
11.17.2 Aragen Life Sciences Business Overview
11.17.3 Aragen Life Sciences In Vitro ADME-Tox Introduction
11.17.4 Aragen Life Sciences Revenue in In Vitro ADME-Tox Business (2019-2024)
11.17.5 Aragen Life Sciences Recent Development
11.18 Sai Life Sciences
11.18.1 Sai Life Sciences Company Detail
11.18.2 Sai Life Sciences Business Overview
11.18.3 Sai Life Sciences In Vitro ADME-Tox Introduction
11.18.4 Sai Life Sciences Revenue in In Vitro ADME-Tox Business (2019-2024)
11.18.5 Sai Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global In Vitro ADME-Tox Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Small Molecules
Table 3. Key Players of Biologics
Table 4. Global In Vitro ADME-Tox Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global In Vitro ADME-Tox Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global In Vitro ADME-Tox Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global In Vitro ADME-Tox Market Share by Region (2019-2024)
Table 8. Global In Vitro ADME-Tox Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global In Vitro ADME-Tox Market Share by Region (2025-2030)
Table 10. In Vitro ADME-Tox Market Trends
Table 11. In Vitro ADME-Tox Market Drivers
Table 12. In Vitro ADME-Tox Market Challenges
Table 13. In Vitro ADME-Tox Market Restraints
Table 14. Global In Vitro ADME-Tox Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global In Vitro ADME-Tox Market Share by Players (2019-2024)
Table 16. Global Top In Vitro ADME-Tox Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro ADME-Tox as of 2023)
Table 17. Ranking of Global Top In Vitro ADME-Tox Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by In Vitro ADME-Tox Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In Vitro ADME-Tox Product Solution and Service
Table 21. Date of Enter into In Vitro ADME-Tox Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In Vitro ADME-Tox Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global In Vitro ADME-Tox Revenue Market Share by Type (2019-2024)
Table 25. Global In Vitro ADME-Tox Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global In Vitro ADME-Tox Revenue Market Share by Type (2025-2030)
Table 27. Global In Vitro ADME-Tox Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global In Vitro ADME-Tox Revenue Market Share by Application (2019-2024)
Table 29. Global In Vitro ADME-Tox Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global In Vitro ADME-Tox Revenue Market Share by Application (2025-2030)
Table 31. North America In Vitro ADME-Tox Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America In Vitro ADME-Tox Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America In Vitro ADME-Tox Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe In Vitro ADME-Tox Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe In Vitro ADME-Tox Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe In Vitro ADME-Tox Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific In Vitro ADME-Tox Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific In Vitro ADME-Tox Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific In Vitro ADME-Tox Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America In Vitro ADME-Tox Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America In Vitro ADME-Tox Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America In Vitro ADME-Tox Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa In Vitro ADME-Tox Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa In Vitro ADME-Tox Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa In Vitro ADME-Tox Market Size by Country (2025-2030) & (US$ Million)
Table 46. Charles River Company Detail
Table 47. Charles River Business Overview
Table 48. Charles River In Vitro ADME-Tox Product
Table 49. Charles River Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 50. Charles River Recent Development
Table 51. Labcorp Company Detail
Table 52. Labcorp Business Overview
Table 53. Labcorp In Vitro ADME-Tox Product
Table 54. Labcorp Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 55. Labcorp Recent Development
Table 56. Envigo Company Detail
Table 57. Envigo Business Overview
Table 58. Envigo In Vitro ADME-Tox Product
Table 59. Envigo Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 60. Envigo Recent Development
Table 61. Curia Company Detail
Table 62. Curia Business Overview
Table 63. Curia In Vitro ADME-Tox Product
Table 64. Curia Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 65. Curia Recent Development
Table 66. Evotec Company Detail
Table 67. Evotec Business Overview
Table 68. Evotec In Vitro ADME-Tox Product
Table 69. Evotec Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 70. Evotec Recent Development
Table 71. Bioduro-Sundia Company Detail
Table 72. Bioduro-Sundia Business Overview
Table 73. Bioduro-Sundia In Vitro ADME-Tox Product
Table 74. Bioduro-Sundia Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 75. Bioduro-Sundia Recent Development
Table 76. Lonza Company Detail
Table 77. Lonza Business Overview
Table 78. Lonza In Vitro ADME-Tox Product
Table 79. Lonza Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 80. Lonza Recent Development
Table 81. WuXi AppTec Company Detail
Table 82. WuXi AppTec Business Overview
Table 83. WuXi AppTec In Vitro ADME-Tox Product
Table 84. WuXi AppTec Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 85. WuXi AppTec Recent Development
Table 86. IQVIA Company Detail
Table 87. IQVIA Business Overview
Table 88. IQVIA In Vitro ADME-Tox Product
Table 89. IQVIA Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 90. IQVIA Recent Development
Table 91. Tecan Group Company Detail
Table 92. Tecan Group Business Overview
Table 93. Tecan Group In Vitro ADME-Tox Product
Table 94. Tecan Group Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 95. Tecan Group Recent Development
Table 96. Pharmaron Company Detail
Table 97. Pharmaron Business Overview
Table 98. Pharmaron In Vitro ADME-Tox Product
Table 99. Pharmaron Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 100. Pharmaron Recent Development
Table 101. Shanghai Medicilon Company Detail
Table 102. Shanghai Medicilon Business Overview
Table 103. Shanghai Medicilon In Vitro ADME-Tox Product
Table 104. Shanghai Medicilon Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 105. Shanghai Medicilon Recent Development
Table 106. ChemPartner Company Detail
Table 107. ChemPartner Business Overview
Table 108. ChemPartner In Vitro ADME-Tox Product
Table 109. ChemPartner Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 110. ChemPartner Recent Development
Table 111. Joinn Laboratories Company Detail
Table 112. Joinn Laboratories Business Overview
Table 113. Joinn Laboratories In Vitro ADME-Tox Product
Table 114. Joinn Laboratories Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 115. Joinn Laboratories Recent Development
Table 116. RTI International Company Detail
Table 117. RTI International Business Overview
Table 118. RTI International In Vitro ADME-Tox Product
Table 119. RTI International Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 120. RTI International Recent Development
Table 121. Eurofins Scientific Company Detail
Table 122. Eurofins Scientific Business Overview
Table 123. Eurofins Scientific In Vitro ADME-Tox Product
Table 124. Eurofins Scientific Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 125. Eurofins Scientific Recent Development
Table 126. Aragen Life Sciences Company Detail
Table 127. Aragen Life Sciences Business Overview
Table 128. Aragen Life Sciences In Vitro ADME-Tox Product
Table 129. Aragen Life Sciences Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 130. Aragen Life Sciences Recent Development
Table 131. Sai Life Sciences Company Detail
Table 132. Sai Life Sciences Business Overview
Table 133. Sai Life Sciences In Vitro ADME-Tox Product
Table 134. Sai Life Sciences Revenue in In Vitro ADME-Tox Business (2019-2024) & (US$ Million)
Table 135. Sai Life Sciences Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vitro ADME-Tox Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global In Vitro ADME-Tox Market Share by Type: 2023 VS 2030
Figure 3. Small Molecules Features
Figure 4. Biologics Features
Figure 5. Global In Vitro ADME-Tox Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global In Vitro ADME-Tox Market Share by Application: 2023 VS 2030
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Government and Academic Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. In Vitro ADME-Tox Report Years Considered
Figure 11. Global In Vitro ADME-Tox Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global In Vitro ADME-Tox Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global In Vitro ADME-Tox Market Share by Region: 2023 VS 2030
Figure 14. Global In Vitro ADME-Tox Market Share by Players in 2023
Figure 15. Global Top In Vitro ADME-Tox Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro ADME-Tox as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by In Vitro ADME-Tox Revenue in 2023
Figure 17. North America In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America In Vitro ADME-Tox Market Share by Country (2019-2030)
Figure 19. United States In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe In Vitro ADME-Tox Market Share by Country (2019-2030)
Figure 23. Germany In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific In Vitro ADME-Tox Market Share by Region (2019-2030)
Figure 31. China In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America In Vitro ADME-Tox Market Share by Country (2019-2030)
Figure 39. Mexico In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa In Vitro ADME-Tox Market Share by Country (2019-2030)
Figure 43. Turkey In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia In Vitro ADME-Tox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Charles River Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 46. Labcorp Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 47. Envigo Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 48. Curia Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 49. Evotec Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 50. Bioduro-Sundia Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 51. Lonza Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 52. WuXi AppTec Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 53. IQVIA Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 54. Tecan Group Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 55. Pharmaron Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 56. Shanghai Medicilon Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 57. ChemPartner Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 58. Joinn Laboratories Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 59. RTI International Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 60. Eurofins Scientific Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 61. Aragen Life Sciences Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 62. Sai Life Sciences Revenue Growth Rate in In Vitro ADME-Tox Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
